Subscribe to RSS
DOI: 10.1055/s-0044-1789620
Clinical and Molecular Aspects of Craniofrontonasal Syndrome due to Contiguous Gene Deletion Involving AWAT2, EFNB1, EDA, OTUD6A, and PJA1 Genes
Funding None declared.
Abstract
Craniofrontonasal syndrome (CFNS; Online Mendelian Inheritance in Man [OMIM] 340110) is an infrequent X linked disorder characterized by specific facial features and digital abnormalities with or without visceral anomalies. There is a peculiar paradoxical difference in severity of the phenotype in heterozygous females compared to hemizygous males. Here, we present a case where the mother, with clinical features of the syndrome, had terminated her previous pregnancy as the fetus had partial agenesis of the corpus callosum. Exome sequencing of the mother revealed no pathogenic variants related to the phenotype. Chromosomal microarray revealed 1.3-Mb pathogenic heterozygous deletion in chromosome X encompassing the Xq13.1 region with five OMIM genes, including EFNB1 gene related to craniofrontonasal syndrome. Detailed phenotyping of the parents and exact genetic etiology with molecular mechanism is important to arrive at a definitive diagnosis crucial for genetic counseling and definitive prenatal testing.
Keywords
craniofrontonasal syndrome - exome sequencing - contiguous gene deletion - EFNB1 gene - paradoxical inheritancePublication History
Article published online:
16 September 2024
© 2024. Society of Fetal Medicine. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Toteja N, Khera D, Sasidharan R. Craniofrontonasal dysplasia. Sudan J Paediatr 2022; 22 (01) 119-120
- 2 Inoue Y, Sakamoto Y, Sugimoto M. et al. A family with craniofrontonasal syndrome: the first report of familial cases of craniofrontonasal syndrome with bilateral cleft lip and palate. Cleft Palate Craniofac J 2018; 55 (07) 1026-1029
- 3 Wieland I, Weidner C, Ciccone R. et al. Contiguous gene deletions involving EFNB1, OPHN1, PJA1 and EDA in patients with craniofrontonasal syndrome. Clin Genet 2007; 72 (06) 506-516
- 4 Howaldt A, Nampoothiri S, Yesodharan D, Udayakumaran S, Subash P, Kornak U. Four novel mutations in EFNB1 in Indian patients with craniofrontonasal syndrome. J Hum Genet 2019; 64 (09) 867-873
- 5 van den Elzen ME, Twigg SRF, Goos JAC. et al. Phenotypes of craniofrontonasal syndrome in patients with a pathogenic mutation in EFNB1. Eur J Hum Genet 2014; 22 (08) 995-1001
- 6 Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 2005; 6 (06) 462-475
- 7 Davy A, Bush JO, Soriano P. Inhibition of gap junction communication at ectopic Eph/ephrin boundaries underlies craniofrontonasal syndrome. PLoS Biol 2006; 4 (10) e315
- 8 Twigg SRF, Babbs C, van den Elzen MEP. et al. Cellular interference in craniofrontonasal syndrome: males mosaic for mutations in the X-linked EFNB1 gene are more severely affected than true hemizygotes. Hum Mol Genet 2013; 22 (08) 1654-1662
- 9 Niethamer TK, Teng T, Franco M, Du YX, Percival CJ, Bush JO. Aberrant cell segregation in the craniofacial primordium and the emergence of facial dysmorphology in craniofrontonasal syndrome. PLoS Genet 2020; 16 (02) e1008300
- 10 Babbs C, Stewart HS, Williams LJ. et al. Duplication of the EFNB1 gene in familial hypertelorism: imbalance in ephrin-B1 expression and abnormal phenotypes in humans and mice. Hum Mutat 2011; 32 (08) 930-938